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Abstract
Globally, there are almost 300 million people blind and visually impaired and 
over 90% live developing countries. The gross disparity in access to ophthalmolo-
gists limits the ability to accurately diagnose potentially blinding conditions like 
cataract, glaucoma, trachoma, uncorrected refractive error and limits timely 
initiation of medical and surgical treatment. Since 85% of blindness is preventable, 
bridging this chasm for care is even more critical in preventing needless blindness. 
Many low-income countries must rely on community health workers, physician 
assistants, and cataract surgeons for primary eye care. Ophthalmology in low-
income countries (LIC) is further challenging due to complexities brought from 
tropical climates, frail electric grids, poor road and water infrastructure, limited 
diagnostic capability and limited treatment options. Vision 2020 set the goal of 
eliminating preventable blindness by 2020 despite formidable obstacles. Innovative 
technologies are emerging to test visual acuity, correct refractive error quickly and 
inexpensively, capture retinal images with portable tools, train cataract surgeons 
using simulators, capitalize on mHealth, access ophthalmic information remotely. 
These advancements are allowing nonspecialized ophthalmic practitioners to pro-
vide low-cost, high impact eye care in resource-limited regions around the world.
Keywords: Vision 2020, preventable blindness, smartphone photography, mHealth
1. Introduction
When refractive error and presbyopia are included, more than 1.6 billion people 
suffer from some form of visual impairment worldwide [1]. Unfortunately, the 
greatest burden of visual blindness and impairment falls to the poor who are living 
in LIC where access to resources and eye care providers is scarce. According to a 
published report in 2010, the leading causes of blindness (defined as visual acuity 
in the better eye less than 3/60) were cataracts (33% of total cases of blindness), 
uncorrected refractive error (21% of cases), and macular degeneration (7% of 
cases) [2]. The leading causes of moderate and severe vision impairment (defined 
as visual acuity in the better eye less than 6/18 but at least 3/60) were uncorrected 
refractive error (53% of cases), cataract (18%), and macular degeneration (3%). 
However, these causes varied widely by region. Avoidable vision loss, due to condi-
tions such as uncorrected refractive error, cataract, etc., which are treatable, is 
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still a major problem worldwide. It accounts for 85% of all cases of vision loss. The 
number of avoidable cases of blindness is also increasing over time. By 2020, there 
will be a projected 76 million blind individuals globally.
The prevalence of childhood blindness and vision impairment (CBVI) var-
ies based on socioeconomic development. For example, in high-income counties 
(HIC), the prevalence of blindness is 0.3 per 1000 children, while in LICs it is 1.5 
per 1000 children. The number of blind children is estimated to be 1.4 million, 
with up to three-quarters of the blind children living in the poor regions of Africa 
and Asia. Some of the major causes of blindness and visual impairment in children 
of LIC include vitamin A deficiency, rubella cataracts, corneal scarring from 
measles, the use of harmful toxic eye remedies and ophthalmia neonatorum [3]. 
Immunizations and vitamin A supplements are proven, cost-effective preventions.
Despite these challenges, significant technological innovations provide an 
optimistic view for ending preventable blindness. This chapter will discuss the 
innovative devices that are currently being tested and used in order to promote eye 
health worldwide and help achieve the goals set forth by Vision 2020. These include 
low-cost, portable means of detecting refractive error and imaging the fundus, 
self-refracting glasses that do not require an eye care specialist, simulators to teach 
cataract surgery more efficiently, artificial intelligence that diagnose disease, and 
portable auto-phoropters. Future studies to validate these new innovations will be 
an important field of research.
2. Vision 2020
In 1999, the World Health Organization (WHO) launched an initiative called 
Vision 2020: The right to sight [4]. The objective of the initiative was to eliminate 
avoidable causes of blindness around the world and prevent the projected increase 
of avoidable visual impairment cases worldwide. Since then more than 90 nongov-
ernmental organizations, agencies, institutions, and corporations have pledged 
their support of this initiative. If successful, this would reduce the cases of blind-
ness from 76 million to below 25 million. The program is based on several core prin-
ciples: human resource development, infrastructure and technology development, 
disease control, advocacy, and collaboration among stakeholders in eye health.
A 2014 study assessed the progress of 21 sub-Saharan African (SSA) countries 
toward the specific goals placed by the Vision 2020 [5]. The results were not encour-
aging. First, the authors noted that it was exceedingly difficult to access information 
on human resources for eye health within the study population, a necessary set of 
data in order to assist Vision 2020 planning. Secondly, the study found that few of 
the 21 countries met the human resources goals for the 2011 benchmark: only five 
countries met the goal for the number of ophthalmologists/cataract surgeons, four 
countries for ophthalmic nurses, and only two countries for cataract surgical rates 
(cataract surgeries as a ratio of operations per million population per year). No 
country met the goal target for number of optometrists, even when other personnel 
who perform refraction were considered. Overall, sub-Saharan African met three-
quarters of its target for number of ophthalmologists, but only one-quarter of its 
goal for the number of ophthalmic nurses. Thirdly, the study found significant geo-
graphic inequities with higher concentrations of human resources in urban cities, 
seemingly at the expense of rural areas. As a result, there is still significant progress 
to be made. Compounding these existing provider shortages are increasing clinical 
care needs due to infectious epidemics, such as Ebola and Zika, and noncommuni-
cable diseases, diabetes and hypertension, which pose a different epidemic threat 
level by 2030.
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3. Innovative technologies
3.1 Refractive error testing kits
Uncorrected refractive error is the most common cause of preventable visual 
impairment worldwide [6]. The measurement of refractive error typically requires 
an eyecare specialist, a limiting factor in the provision of eyeglasses in LICs. One 
study in rural India found that more than 65% of a population with high rates of 
refractive error correctable with glasses were not wearing them due to inadequate 
access [7]. While in the U.S., there is approximately one eyecare professional for 
every 5500 people, that figure is only one per 1 million in certain parts of Africa 
[8, 9]. Such disparity has negative implications on sustaining educational and 
occupational productivity of these affected communities. The annual loss in global 
GDP due to distance visual impairment caused by uncorrected refractive error was 
an estimated $202 billion in 2007. In this section, we review various new techno-
logical innovations that are able to measure refractive error in a mobile, low-cost 
manner with limited personnel.
The Portable Eye Examination Kit (PEEK) solutions are built on smartphone 
technology which includes visual acuity apps and hardware, PEEK Retina. The 
smartphone app, Peek Acuity Pro, allows users to go through a brief tutorial 
and then tests visual acuity through a gamelike environment using a tumbling E 
(https://mts.intechopen.com/download/index/process/335/authkey/4eb406ca
f486438fcbbf872a81061e61). Peek Acuity has been shown to be an accurate and 
validated method to quickly test visual acuity [10]. Readings can be obtained in 
Imperial (20/20), Metric (6/6) or LogMar (0) for clinical research. The measured 
visual acuity can be simulated with a split screen view of a classroom chalkboard 
on one side compared to 20/20 view on the opposite side. The PEEK Retina allows 
fundus photography of the optic nerve and macula using a smartphone hardware 
attachment (Figures 1 and 2).
A qualitative study [11] in the Nakuru district of Kenya accessed the usability 
and acceptability of PEEK for providing eye care. In a region with a lack of adequate 
eye care services, patients found the PEEK system highly practical, as it allowed 
health practitioners to visit them in their own rural areas. This is particularly 
significant in regions with poor infrastructure and roads that can make transporta-
tion difficult. The PEEK system was also able to save patient time, overcoming the 
challenge of taking time off work and losing potential income. In regions where 
Figure 1. 
The peek retina device.
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eye problems are not perceived to be serious enough to warrant travel for care, 
barriers such as transportation become significant obstacles in providing eye care 
services. Patients and PEEK-trained healthcare workers appeared to have positive 
attitudes toward using mobile health technology, referring to it as “innovative” and 
“new.” Many patients thought it to be efficient and cost-saving. Reasons for prefer-
ring PEEK were shorter exam times, simplicity, being seen at home, and increased 
ability to cover the population in need. However, some patients did prefer the 
traditional examination due to the ease of reading larger letters.
Another study [12] investigated whether a PEEK-based system could increase 
hospital follow-up for school aged children who were screened for visual impair-
ment. Subjects in the experimental group determined to have visual impairment 
were shown their simulated sight on a smartphone and given a printout of this 
simulation. This simulation was then shared with the subjects’ teachers and parents 
on a handout, which also included a written hospital referral letter. Parents in the 
experimental group were also sent regular SMS reminders to attend their follow-up 
appointment at the hospital. Compared to a control group which only received 
a referral letter without any simulation or SMS follow-up, the study found that 
visually impaired subjects in the PEEK group were significantly more likely to 
follow up at the hospital versus the control group with an odds ratio of 7.35 (95% CI 
3.49–15.47). While the SMS reminders may have played a significant role in these 
results, future studies should analyze the effect of the simulation alone in increas-
ing referral follow ups. However, one potential problem of increased screenings and 
referrals with PEEK or similar devices would be the inability of providers to handle 
the increased caseload. Nevertheless, PEEK have played a major role in addressing 
the shortage of vision care in underprivileged communities worldwide.
EyeNetra Inc. (Cambridge, MA) produces similar smartphone-based autore-
fractors for refractive error measurements (Figure 3). The autorefractor, NETRA, 
measures sphere, cylinder, axis, and pupillary distance in a virtual reality environ-
ment similar to that of PEEK. The age range for the NETRA is 10–65 years. The 
process takes 2 minutes and requires no power source. The company claims to be as 
accurate as autorefractors that cost $45,000, with its own product priced at $1290. 
Its system has an accuracy of 0.35D and comes with an extended battery for 2 days 
of testing without requiring a charge. It can withstand a drop from 1 m without 
breaking or losing accuracy, a convenient feature for users intending on traveling 
extensively with the device. EyeNetra also has a lensometer, called the Netrometer, 
that costs $975, and a phoropter, called the Netropter, which costs $699. The 
Figure 2. 
Peek retina can be attached to a smartphone for portable fundal examinations.
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combination of the three products can fit within a small suitcase to set up a mobile 
clinic virtually anywhere and provide all the tools needed to prescribe eyeglasses. 
The complete kit costs $2990. The EyeNetra products have been deployed in more 
than 90 countries worldwide.
In a study sponsored by EyeNetra, Inc., NETRA was compared with Zeiss iProfile 
Plus and subjective refraction on teenagers of age ranging from 14 to 18 years [13]. 
When NETRA was compared with subjective refraction, the average absolute dif-
ference in sphere was 0.48D, cylinder was 0.30D, and axis was 7.32°. One the other 
hand, when Zeiss iProfile Plus was compared with subjective refraction, the average 
absolute difference in sphere was 0.29D, cylinder was 0.45D, and axis was 11°.
Other handheld autorefractors include Retinomax 3, HAR 800/880, QuickSee, 
PlusOptix, Suresight, SVOne, WA Spot, and 2Win. Retinomax K-plus3, developed 
by Righton, is a handheld autorefractor and keratometer. It weighs around 1 kg and 
is able to perform keratometer and refraction measurements in around 0.34 sec-
onds. Its battery life is around 80 minutes. The age range of Retinomax K-plus3 is 
5–50 years old with a sphere range of −18.00D to +23.00D. However, pricing can 
be an issue to certain eyecare providers as it is priced around USD 11,000. HAR-
800/880, developed by MOPTIM Imaging Technique Co. (Shenzhen, China), is 
a portable autorefractor that weighs approximately 0.9 kg with a battery life of 
6 hours. The intended patient age range is 10–65 years with the sphere range of 
−6.0D to +8.0D. HAR-800/880 is priced at USD 4300. QuickSee is an autorefractor 
developed by PlenOptika (Massachusetts, USA). It is priced around USD 6000. It 
weighs around 1 kg and is able to perform refraction in 10 seconds. Its intended 
patient age is 5–85 years with spherical range of −10D to +10D. The battery life is 
approximately 6–8 hours. QuickSee has already been compared to experienced 
refractionists in rural south India, which found only small benefit to using subjec-
tive refraction over autorefraction [14]. More than half of the patients reported 
either no preference or preferred the autorefractor over subjective refraction. 
SVOne, developed by Smart Vision Labs (New York, NY), is a handheld autorefrac-
tor that weighs around 0.5 kg and costs USD 10,000. The intended patient age is 
5–50 years with spherical range of −14D to +14D. It has been tested in LICs like 
Boliva by the Friends of Bolivia Foundation, Inc. PlusOptix, WA Spot and 2Win are 
handheld autorefractors intended for patients under the age of eight. The price of 
these autorefractors range from USD 6000–8000.
3.2 Self-adjustable glasses
Self-adjustable glasses are a recent innovation in the realm of optics and refrac-
tive error treatment. Also known as self-refraction, self-adjustable glasses look 
Figure 3. 
The EyeNetra system includes an autorefractor, lensometer, and a phoropter (shown adjacent to a standard 
near card for size comparison).
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like any other set of glasses. A well-known set of self-adjustable glasses, Adspecs 
(Adaptive Eyecare, Oxford, UK), were developed by Professor Joshua Silver in 
conjunction with Dow Corning and Center for Vision in the Developing World 
(CVDW). Adspecs use lenses that are composed of two flexible membranes capable 
of moving inward or outward depending on the amount of silicone solution 
contained between them (Figure 4). The amount of the solution can be altered 
by the user using a syringe which moves fluid into or out of each lens. When fluid 
is pumped in, the curvature and power of the lens is increased. The user adjusts 
the amount of fluid until proper vision is attained, thereby correcting myopia or 
hyperopia. Another type of self-refracting glasses, USee, work by using pop-in 
best-sphere lenses (Figure 5). On the other hand, a design known as Alvarez optics 
uses two lens systems that move relative to each other in a spectacle frame, causing 
changes in lens power. Types of glasses that use this design are the FocusSpecs, 
Adlens, and Eyejusters.
Figure 5. 
USee glasses adjust refractive power by using pop-in, best-sphere lenses.
Figure 4. 
Adspecs glasses can quickly adjust refractive power based on the amount of silicone solution injected into the 
spectacles.
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The first iteration of the Adspecs glasses cost between $18 and 19 to produce 
and the price has been decreasing ever since [15]. Studies have shown that Adspecs 
could lead to excellent visual outcomes [16]. A study in rural China found that, 
while visual acuity was slightly worse with self-refraction versus automated or 
subjective refraction, acuity was still very good [17]. Moreover, a study in urban 
Chinese children similarly found good visual acuity with self-refraction, but greater 
spherical and cylindrical refractive errors were associated with less accurate results 
as the range for the devices are limited to −6 to +6 D. Additionally, the adjustable 
glasses could not correct astigmatism [18]. Adjustable glasses are easy to use as is 
evident in a study that looked at users of USee which found positive results in 95% 
of the users [19].
Concerns regarding self-refracting glasses include the cosmetic appearance, the 
limited range of correction, inability to correct astigmatism, and compliance with 
international standards. The Adspecs have the additional limitation that once the 
glasses are self-adjusted and the power is fixed, they are unalterable. Despite being 
less expensive than traditional spectacles, cost is still a major barrier to self-adjustable 
glasses. One study in East Timor showed that nearly half the population was not 
willing to pay more than $1 for a pair of glasses [20]. Thus further reductions in cost 
are paramount for making the glasses affordable to worldwide.
3.3 Smartphone applications
Many iOS and Android applications exist for use in eye care and represent 
another low-cost tool for providing eye care globally. They generally fall within 
three categories: patient assessment tools, patient education tools, and health-
care reference tools [21]. Many of the applications have redundant functions. 
For example, countless applications are available to visual acuity. Validation in a 
low-income setting is critical to compare applications to gold standard methods 
which can rely on calibration, optotype, distance, lamination and cultural settings. 
Applications also differ in the number of features they offer, price point, quality 
of user interface, and, perhaps most importantly, whether they continue to be 
supported by the developer over time. An analysis of the iTunes store shows that 
multiple applications from previous reviews [21] are no longer supported by the 
developers. This demonstrates that ophthalmic applications are part of a dynamic 
market that is ever-changing, with new applications entering the market each year 
with older applications exiting the marketplace. This presents the need for users 
to focus on applications that continue to be upgraded with subsequent iOS and 
Android updates.
The Eye Handbook (Cloud Nine Development) is the smartphone application 
currently most highly recommended by the authors for use in LICs (Figure 6). It is 
the most popular and successful application available in eye care [22]. As of 2018, it 
had over 2 million downloads. The Eye Handbook (EHB) is being used worldwide 
with 50% of downloads in North America, 20% in Europe, and 10% in each Asia 
and Australia [23]. While there are surely multiple equality applications that cur-
rently exist, the EHB has several significant advantages. First, it has shown to stand 
the test of time. EHB was developed in 2010 and continues to be supported and 
upgraded by the developers. Second, EHB is a free application thus making it ideal 
for use in LICs. Many other applications with similar features charge several dollars 
(USD), which can be a significant expense for practitioners worldwide. Third, EHB 
is a comprehensive resource with multiple features, allowing users to avoid down-
loading several different applications. It includes many different calculators (i.e. 
IOL calculators, glaucoma risk, etc.), patient assessment tools (amsler grid, visual 
acuity testing, OKN drum, etc.), medication information (indications, dosing, etc.), 
Novel Diagnostic Methods in Ophthalmology
8
and much more. EHB also contains a comprehensive manual of different diseases 
and includes their epidemiology, pathophysiology, signs and symptoms, differential 
diagnosis, workup, treatment, and follow up – all of which can be incredibly useful 
for eye care professionals with limited ophthalmic training in LICs.
3.4 Smartphone-assisted fundoscopy
In addition to the scarcity of ophthalmologists globally, another challenge facing 
the fight against global blindness is the lack of ophthalmic equipment needed for 
proper eye care. Given the explosion of mobile phones that 96% of the world’s 
population now owns, the innovations in fundus photography highlight the ability 
of smartphones to photograph the fundus [24] and use the smartphone in combina-
tion with a 20D condensing lens to capture wider field images of pathology [25].
Traditional ophthalmic equipment, such as office-based cameras are expensive, 
bulky, immobile and unsuitable for reaching patients in rural areas. Newer develop-
ments in technology are replacing our reliance on large equipment and allowing us 
Figure 6. 
Menu of The Eye Handbook smartphone application.
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to visualize the eye in a mobile and more cost-efficient manner. Smartphone-based 
technologies can now act as slit lamps, direct ophthalmoscopes, and indirect oph-
thalmoscopes. Table 1 lists some of the products currently available. While these 
images will not be as sharp as those achieved with traditional cameras, they are of 
adequate resolution for interpretation. This development will allow eye care provid-
ers to have more access to imaging technologies, which provide imaging of harder-
to-reach patients in rural areas with geo-tagging and wireless transfer of results to 
distantly-located specialists for appropriate management. One study found that 
even nonophthalmologists can be trained to effectively capture fundus images 
in a rural area [26]. This section draws greatly from the 2018 literature review by 
Barikian et al. [27].
Disadvantages of smartphone-based imaging are the high intensity of the phone 
light source, which constricts the pupil. However, applications such as Shutter can 
be used to tailor the intensity and exposure time of the flash for optimal illumina-
tion. Another disadvantage is achieving proper beam alignment.
In addition to smartphone-based imaging, standalone handheld camera tech-
nologies also allow portable image capture. These cameras are lightweight and 
capture quality retinal images. Examples of such devices include the Panoptic 
(Welch Allyn, Skaneateles Falls, NY), Volk Pictor (Volk Optical, Mentor, OH), 
Category Device Manufacturer Validated 
in LIC?
FoV Pupillary 
dilation
Cost 
(USD)
Slit lamp imaging EyePhotoDoc EyePhotoDoc (Fullerton, 
CA)
No N/A Required $300
Portable Slit 
Lamp iPhone 4 
Image Adapter
Keeler (Broomall, PA) No N/A Required $203
SteadyPix 
Telescope 
Photoadapter
Orion (Cupertino, CA) No N/A Required $48
Zarf iPhone 
Adapter
Zarf (Spokane, WA) No N/A Required $520
Create-your-own 
adapter
www.instructables.com
www.eyewiki.aao.org
No N/A Required N/A
Direct 
ophthalmoscopy
iExaminer Welch Allyn (Skaneateles 
Falls, NY)
No 25° Optional $800
D-Eye Adapter D-EYE (Padua, Italy) No 20° Optional $435
PEEK Retina Peek Vision (London, UK) Yes [28] 20–30° Optional $245
Ocular Cellscope University of California 
(Berkeley, CA)
No 55° Required N/A
Remidio FOP Remidio Innovative Solutions 
(Bangalore, India)
No 45° Required $6500
Indirect 
ophthalmoscopy
Smartphone and 
lens
Multiple No 50° Required $200
MII Ret Cam MII Ret Cam (Coimbatore, 
India)
No 40–50° Required $350
oDocs Open source No 40° Required $0
Volk iNview Volk Optical (Mentor, OH) No 50° Optional $995
Table 1. 
Products available for smartphone-based imaging.
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VersaCam (Nidek, Gamagori, Japan), Horus Scope (JedMed, St. Louis, MO), and 
Smartscope (Optomed, Oulu, Finland). A limitation of such devices is the need 
for proper manual alignment of the illuminating beam with the optical axis for 
good-quality images. They also lack the ability to integrate with various apps as 
smartphone-based cameras and tend to be fragile. More importantly, these devices 
are cost-prohibitive for LICs.
3.5 Ultrasound
VuPad (Sonomed Escalon) and Accutome offer the only portable laptop size 
ultrasounds that can be used in low-income countries. They are expensive at over 
$10 k and do not yet accommodate smart phone utilization. Ultrasound (US) is a 
noninvasive, very easy to operate tool that plays an important role in clinical oph-
thalmology. It is used for the visualization of anatomy and various ocular pathology 
such as retinal detachment and intraocular tumors. Ultrasound becomes especially 
important if visualization of fundus becomes obscured by opaque elements includ-
ing vitreous hemorrhage or dense mature cataracts commonly encountered in 
LIC. Butterfly iQ is the first portable US probe that can be plugged directly into a 
smartphone to visualize various parts of the body but is not yet approved for the eye 
(Figure 7). The probe uses a single silicone chip that replaces traditional transducer 
system. Clinicians can switch between various types of transducers, such as linear, 
curved or phased, without the need of switching probes. Moreover, the Butterfly 
iQ application allows clinicians to organize and remotely access imaging studies 
through the Butterfly Cloud. The Butterfly Cloud is HIPAA compliant and the 
application is developed in a way that makes it easy to share studies between various 
clinicians across the globe. Butterfly iQ weighs around 0.7 lbs. and is small enough 
to fit in pants pocket and costs about $2000. Butterfly iQ is being utilized for point 
of care ultrasound by physicians and emergency room physicians but could evolve 
as the first smartphone based ocular ultrasound. It has future potential to be used 
by visual care providers in resource poor areas for diagnosing ocular pathology. 
Figure 7. 
Butterfly iQ is a portable ultrasound probe that can be plugged into any smartphone to visualize various 
anatomical features, including the eye.
11
Innovative Diagnostic Tools for Ophthalmology in Low-Income Countries
DOI: http://dx.doi.org/10.5772/intechopen.83455
The Clarus Portable Ultrasound is palm sized, connects to a wireless smartphone 
or tablet, but is not yet marketed for ophthalmology use. Its rugged, portable and 
waterproof design makes it ideal for global health (relief camp settings/medical 
missions) where it has been used for ophthalmology as part of a FAST exam.
A group from the University of Arizona assessed a new ultrasound system, the 
Vevo 2100 (VisualSonics, Toronto, Ontario, Canada) and its ability to examine 
structures of the anterior and posterior segments [28]. This system is unique in that 
it was able to implement high-frequency (>20 MHz) linear ultrasonic arrays that 
were not previously available in ophthalmic practice. Previous ultrasound technolo-
gies used single-element transducers, while the Vevo 2100 uses linear array technol-
ogy with more than 100 piezoelectric elements packed into the face of the transducer 
probe. The new technology allows users to examine the eye quickly (approximately 
10 seconds) with high resolution (30–60 μm). Additionally, it allows the scan to 
be shown in three-dimensions at different planes with sagittal, transverse, and 
coronal sections. This allows users to measure the location, dimensions, and volume 
of lesions or parts of the eye, which could be useful for providing information on 
the growth of lesions over time. The technology could also be used to determine 
the extent of traumatic injury and location of foreign bodies. A doppler function 
also allows examination of the temporal artery as well as vessels of the optic nerve 
head. However, despite the accurate images, the Vevo 2100 provides the anterior and 
posterior segments, and its high cost makes it a limiting factor for use in LIC.
3.6 mHealth in LICs
Mobile health, also referred to as mHealth, refers to the use of short messaging 
service (SMS), wireless data transfer, voice calling, and smartphone applications 
to transmit health-related information or direct medical care. A thorough 2013 
systematic review by Betjeman et al. [29] found that mHealth can be a valuable tool 
in sub-Saharan Africa (SSA) to monitor patients, increase medication adherence, 
promote healthcare worker communication, and assist with disaster response. One 
of the key factors of mHealth is the prevalence of mobile phones even within LICs: 
penetration rates of mobile phones are greater than 70% in SSA [29].
mHealth has been shown to be a cost-effective means of improving medication 
adherence in LICs [29]. A study of 155 patients in South Africa tested the utility of 
SIMpill, a medication dispensing system that uses a SIM card to send an SMS text to 
a central server each time the medication bottle is opened (Figure 8). If the server 
does not receive an SMS before a preset time, a reminder text message is sent to 
the patient’s mobile phone. If there is no response from the patient, an SMS is sent 
to the patient’s healthcare provider for direct follow up. One study found that the 
SIMpill system increased medication adherence rates from 22–60 to 94% [30]. The 
WelTel Kenyal study found that even weekly SMS text messages inquiring about 
patient wellbeing is sufficient to increase self-reported medication adherence and 
HIV viral suppression [31]. The system deployed in this study cost under $8 USD 
per patient per year. Another study in Kenya used a combination of video messages 
and text messages, having the patient’s friends or relatives capture video images 
of the patient taking their medication which is reviewed by nurses for follow up 
if there is low medication adherence. This study found that 50% of the messages 
were not received, mostly due to technical issues [32]. This demonstrates the need 
for a strong technological infrastructure in regions that mHealth is being deployed. 
Based on the results of these studies, mHealth can be an effective and cost-effective 
means to increase medication adherence in LICs with wireless network coverage.
mHealth can also be a means of increasing community health worker (CHW) 
access to health information, access to health information, decision making, and 
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logistical support [29]. A study in Malawi found that CHWs most often used SMS to 
report supply shortages, communicate information with other CHW, and facilitate 
emergency communication [33]. Importantly, this study found that the average cost 
per communication using SMS was one-fifth the cost of communication in areas 
without SMS access. SMS communication took approximately 9 minutes, compared 
to 24 hours in areas without SMS access [33]. Another study found that common 
uses of SMS by CHW were patient referral, drug dosing information, emergency 
support, and reporting patient mortality. This study found that the efficiency of 
SMS communication substantially increased free time of hospital staff, allowing 
staff to treat more patients. These studies show that mHealth can significantly 
increase CHW efficiency while reducing overall healthcare costs in LICs.
mHealth could potentially be used to facilitate health education among patients 
in LICs [29]. One study sent an SMS squiz on HIV awareness to 10,000 cell phone 
subscribers and found significant challenges associated with the use of mHealth as 
a patient education tool [34]. First, the study found that individuals tended to only 
respond to questions for which they knew the correct answer, while skipping other 
questions. This demonstrates that it may be difficult to use mHealth to transmit new 
information to patients. Second, and perhaps more importantly, the study found 
that respondents were more likely to be men. The authors postulated this to be due to 
men having higher rates of mobile phone ownership and literacy. This could indicate 
future difficulty for mHealth to be used as an education tool for women in LICs.
3.7 Remote database access
Rapid Assessment of Avoidable Blindness (RAAB) is a survey system that 
estimates prevalence of avoidable blindness in a population over age 50. The data 
gathered from these surveys are stored in a repository, which not only details the 
prevalence of eye diseases and their causes but also the quality of eye services, 
resources and barriers to care in a specific geographical area. This resource is invalu-
able to researchers and country ministries of health, as it grants them easy access 
to data. Moreover, it allows agencies and eye care providers to focus their efforts on 
regions with the greatest medical need with optimal utilization of limited resources. 
These RAAB surveys can also be completed using a smartphone application devel-
oped by the PEEK Vision project called mRAAB [35]. The mRAAB application 
has increased the quality and efficiency of data entry by allowing the data to be 
entered while the examiner is still with the patient. It has been tested successfully 
Figure 8. 
The SIMpill system sends an SMS message to centrally-located servers, recording each time a patient takes their 
medication.
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in countries such as Tanzania, the Maldives, Madagascar, Uganda, Zimbabwe, and 
Nigeria. The future goal of mRAAB is to integrate PEEK functions such as visual 
acuity assessments and ocular photography with the surveys.
The Open Data Kit is another mobile data collection application that has facili-
tated the collection, management, and access to data in remote and resource-limited 
regions. It is a free and open-source software that is already being used by organiza-
tions such as the WHO, Red Cross, and Red Crescent [36]. Similar to the mRAAB, 
this is a great resource that allows various eye care organizations and providers to 
collect and share data that can increase the effectiveness of their efforts.
Poor cataract outcomes are often detected in RAAB surveys of cataract patients 
in sub-Saharan Africa. The WHO recommends Better Operative Outcomes 
Software Technology (BOOST) to track cataract surgery cases for quality assess-
ment and improvement. BOOST is an application developed by several nongovern-
mental organizations and the Aravind Eye Hospital (Madurai, India) which allows 
cataract surgeons to measure and benchmark their surgical results against others 
in a cloud-based database. It also provides advice on how to improve outcomes 
[37]. The app uses two rounds of data collection. First, users measure visual acuity 
of patients the day after surgery to measure the proportion of patients with good 
(defined as >6/18) and bad (defined as <6/60) visual acuity. Second, for patients 
returning 6 weeks postoperatively with vision less than 6/60, users choose from 
among three reasons for poor vision outcomes (refractive problems, surgical misad-
venture, presence of ocular comorbidity). The app then suggests changes in practice 
for users to help improve their most common causes of poor vision.
3.8 Simulations in cataract surgery
Simulation-based training for cataract surgery is an innovation with substantial 
promise for treating global blindness in LIC. Cataracts account for nearly half of all 
cases of global blindness, the majority being in the developing world [38]. While 
many of these cases can be cured with inexpensive surgical procedures, there is a 
shortage of surgeons to handle the caseload. Trainees in developing countries face 
a lack of equipment and teaching personnel. Simulation-based training could help 
alleviate this shortage of surgeons by providing practice cases without the require-
ment for actual patients. Several simulators currently exist on the market, includ-
ing HelpMeSee (HelpMeSee, New York), Eyesi (VRmagic, Manheim, Germany), 
MicroVisTouch (ImmersiveTouch, Chicago), and Phacovision (Melerit Medical, 
Linköping, Sweden), among others.
The Eyesi is the most prevalent of commercially available simulators in U.S. 
and European ophthalmology residency programs [39]. It is a high-fidelity phaco-
emulsification simulator. The hardware consists of a mannequin headpiece with a 
mechanical eye, which is wired to a computer interface and a microscope, allowing 
the trainee to assume the most realistic posture (Figure 9). Eyesi also includes 
surgical instruments and foot pedals. The system allows users to watch previous 
surgeries to review and improve upon. It consists of different learning modules, 
including anti-tremor training, bimanual training, capsulorhexis, cracking and 
chopping training, forceps training, hydro-dissection maneuvers, intraocular lens 
insertion, irrigation and aspiration, navigation training, and phacoemulsifica-
tion training. VRmagic also produces Eyesi indirect and direct ophthalmoscopes 
for simulation-based training in ophthalmoscopy (Figures 10 and 11). The HMS 
system includes a platform similar to the Eyesi system with a microscope, monitor, 
and instruments attached to robotic arms (Figure 12). The MicroVisTouch system 
includes a blunt-tip handpiece attached to a robotic arm, with a mannequin head-
piece to practice proper hand placement. The handpiece serves as the appropriate 
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Figure 10. 
The VRmagic direct ophthalmoscope allows users to develop the skillset for direct ophthalmoscopy by 
progressively moving through skill modules and case pathology.
Figure 11. 
The VRmagic indirect ophthalmoscope allows users to develop the skillset for binocular indirect ophthalmoscopy 
with a 20D and 28D lens and records the percentage of the retina visualized in focus by the examiner.
Figure 9. 
The VRmagic Eyesi surgical simulator allows users to go through modules of high fidelity simulations of 
phacoemulsification and vitreoretinal surgery steps.
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instrument based on the stage of surgery being performed, from a keratome to 
forceps. The system also includes haptic feedback, a relatively new addition to the 
market for surgery simulators.
A 2015 systematic review of by Thomsen et al. found the overall evidence 
of research in the use of simulators as both training and assessment tools to be 
inadequate [40]. Another recent study by Thomsen [41] tested the Eyesi as a 
training method of 18 surgeons of varying levels of experience. Each surgeon was 
graded based on a previously-validated testing tool for cataract surgery (Objective 
Structured Assessment of Cataract Surgical Skill). The study found that novice sur-
geons benefited by training on the Eyesi, while more experienced surgeons did not. 
Compared with no intervention, simulation-based training has been shown to have 
large improvements in user knowledge, skills, and behaviors, along with moderate 
improvements in patient outcomes across many surgical and medical fields [42]. 
Given the lack of training institutions, wet labs, etc., in LICs, the use of simulators 
can play a key role in training future cataract surgeons.
3.9 The HelpMeSee approach to cataract-induced blindness
A 2013 review by Broyles et al. explains that HMS is doing more than simply 
creating cataract simulation technology. Despite the aforementioned shortcomings 
in the research of simulators, the organization is creating training centers around 
the world that incorporate surgical simulation as well as traditional learning meth-
ods, centered around a textbook written at an 8th grade English level. Their goal is 
to fight global blindness caused by cataracts. These training centers will be located 
within LICs such as Asia, Africa, and Latin America. The intended trainee will 
include health care professionals and individuals without medical training in order 
to create the manpower necessary to meet the global need for surgeons. However, 
HMS predicts that 60% of the trainees will be physicians. Each center will have the 
capacity to train approximately 1000 trainees per year. Only those who successfully 
complete the cognitive training will move forward to surgical training, where they 
will be trained in manual small incision cataract surgery (MSICS), a safe, low-
cost, and rapid method for surgical cataract removal compared to other costlier 
methods.
Figure 12. 
The HelpMeSee simulation system allows users to practice small incision cataract surgery (SICS).
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The graduates then become part of a network of independently-functioning 
MSICS practitioners that are responsible for seeking out treatable cataract cases 
in their practicing area, providing surgical care on a fee-for-service basis, and 
reporting quality metrics via electronic photographs to HMS. The practitioners will 
live and work in the underserved areas HMS hopes to serve. By focusing only on 
cataract surgery, the intention is to create high surgical volumes per practitioner in 
order to drive unit costs of surgery sufficiently low and maintain surgeons’ skills. 
Depending on uptake of surgical services, the cost per surgery could be as low as 
$69 in southeast Asia. Better skill and outcomes will then drive local credibility and 
encourage uptake of the program by locals.
The review forecast that the HMS is able to train 30,000 new surgeons. It 
also models different levels of uptake of HMS surgeries: low (20% of cataract-
caused visually impaired individuals not operated on elsewhere are operated on 
by HMS), medium (50% operated on by HMS), and high (80% operated on by 
HMS). With these assumptions, the model predicts that the projected 134 million 
individuals with cataract-caused blindness in the four identified regions can be 
reduced to 21 million individuals in the case of high uptake (80%). The reduc-
tions are more modest in the medium and low uptake assumptions. The economic 
effect, with visually-impaired individuals now able to work, would mean an 
additional $52 billion of GDP in the Western Pacific Region (i.e., China) if the 
high scenario is met. The increase in GDP would be $18 billion in Southeast Asia 
and $9 billion in the Africa region. However, once the cataract surgery backlog is 
eliminated, there will likely be an oversupply of surgeons. The timeframe depends 
on the uptake of surgical services by region but could be as soon as 2021 in the 
African region. After that point, surgeons would rely on new cases of cataracts 
for business. Surgeons could then possibly serve as referral sources for broader 
ophthalmic services to larger care organizations.
The HMS system faces several obstacles. First, training a new cohort of high-
quality cataract surgeons in an efficient manner will likely pose many challenges. 
Second, it may be challenging for local practitioners to educate patients on the 
need for surgery and bring in sufficient volumes of cases to drive the unit cost 
sufficiently low. It will also be difficult for surgeons to have the high surgical load 
and make time for patient screening and outreach. Third, it may be difficult for 
individuals to travel the distance required to have the surgery. While the surgeons 
will live in the regions they serve; patients living in rural will likely still need to 
travel significant distances for care. This challenge could be reduced by providing 
transportation services at the time of screening by other qualified medical staff. 
Fourth, patients with non-cataract pathologies could be disappointed by the inabil-
ity of practitioners to treat their disease. This could discourage local credibility and 
would require the practitioner to market their services appropriately. Fifth, it will 
be challenging for HMS to monitor quality of care provided due to the volume of 
surgeons operating in multiple different regions worldwide. This increases the need 
for technology-driven quality monitoring via sophisticated imaging.
4. International organizations promoting visual health
There are several leading global organizations dedicated to providing vision 
care. Vision Springs, Eyelliance, Eyesee and Vision for a Nation are some of the 
organizations that focus on providing eyeglasses to low-income countries. Vision 
Springs is an organization that relies on a high-volume low margin business 
model. It employs optical shops in communities with limited access to eye care 
services. These optical shops provide eye exams and low-cost prescription glasses 
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to the community. Vision Springs also partners with local NGOs and businesses 
to distribute eyeglasses using their already established distribution channels. This 
model allows them to distribute glasses to areas in need while keeping the cost as 
low as possible. Eyelliance and Vision for a Nation follow a similar model. Eyesee 
is a student-run organization based in the U.S which collects used eyeglasses and 
distribute them to the poor regions. Since its establishment in 2008, the organiza-
tion has delivered free recycled glasses to countries such as Haiti, Nigeria, Uganda, 
Honduras, and Cambodia.
Another leading organization in global vision care is ORBIS. It is a non-profit 
organization based in New York that operates the Flying Eye Hospital. This mobile 
hospital is the only one of its kind in the world that provides eye restoration inter-
ventions in addition to education and training of local ophthalmic communities 
throughout low-income countries. The organization has been successful in estab-
lishing educational programs in countries such as Bangladesh, Ethiopia, India, and 
Vietnam. These programs have since provided treatments and prevention of various 
ocular diseases like cataracts and trachoma to their communities. ORBIS also 
launched a telemedicine initiative in 2003 called Cybersight. Through Cybersight, 
ophthalmologists in the U.S. are able to connect 24/7 with local community physi-
cians worldwide to offer them with professional consultation and education on 
various surgical techniques and patient cases.
The International Agency for the Prevention of Blindness (IAPB), established 
in 1975, is one of the major organizations that leads international endeavors toward 
blindness intervention. Through its efforts, Vision 2020 was able to be formed in 
collaboration with the WHO. The organization’s goal in the years between 2013 
and 2017 was to promote access to eye health particularly in the most marginalized 
regions of the world. As a result, IAPB sponsors variety of global initiatives such as 
Seeing is Believing, the DR Barometer Project, Our Children’s Vision, The Rotary 
International Service Partnership, and the Vision Alliance [43].
5. Future prospects
One of the most exciting emerging frontiers in ophthalmology is the ability of 
automated devices to diagnose and treat various ocular diseases through artificial 
intelligence (AI). Giant technology companies such as Google and IBM have 
dedicated plenty of resources to developing their own version of AI systems. Such 
systems have shown great promise in playing an important role in patient care. 
For example, Google Brain (AI system developed by Google) was able to detect 
the spread of breast cancer by examining microscopic specimen images of lymph 
nodes. In fact, Google Brain’s performance was comparable and, in some cases, 
superior to that of human pathologists [44]. Similar developments are occurring 
in ophthalmology, in particularly the field of retinal diseases. In 2016, Google 
Brian’s AI system through machine learning was able to “learn” how detect diabetic 
retinopathy and diabetic macular edema from funduscopic photographs [45]. New 
systems are currently being developed to evaluate other ophthalmic disorders such 
as cataract, glaucoma and keratoconus.
These intelligent systems could prove invaluable in global health with the poten-
tial to improve health care affordability, efficiency and accessibility. The system can 
act as an adjunct for eye care capacity building. For example, it could enable non-
medical personnel with a few hours of training to diagnose ocular disease without 
physicians’ interpretation, in turn, expanding medical care to remote regions with-
out practicing ophthalmologists. In addition to serving as a solution to the increased 
shortage of ophthalmologists in low-income countries through simplifying the 
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process of diagnosing ocular diseases, ocular pathology can be diagnosed at earlier 
stages. Diagnosing diseases at earlier stages will allow for earlier intervention and in 
turn yielding better medical outcomes. Moreover, with identification of populations 
with greater disease burden, resources can be focused on those areas for treatment 
to maximize its utility.
The US Food and Drug Administration has recently made history by approv-
ing the first AI retinal diagnostic system called IDx-DR. The system specializes in 
autonomously detecting diabetic retinopathy, one of the major causes of vision loss 
and blindness worldwide. For example, in India, the WHO estimates that around 
32 million people were affected by diabetes mellitus (DM) in 2000. We expect 
the epidemiologic curve to shift from infectious, communicable diseases to non-
communicable diseases in the next decade. By 2030, in India alone, these figures are 
expected to increase to around 80 million people vulnerable to developing diabetic 
retinopathy [46]. Vision loss, as result of this disease, can be easily controlled with 
early detection and management; however, most patients with diabetes in low-
income countries end up without any eye care. However, IDx-DR currently is only 
validated and approved by the FDA for use in the US.
IDx-DR could be a future health solution to identify patients with greatest risk 
early in the disease process, in turn maximizing limited physician resources by 
focusing on patients who need advanced care. Using a fundus camera, an operator, 
who does not require previous ophthalmology knowledge, captures two images 
per eye (Figure 13). These images are automatically sent to a computer system 
that analyzes the images for any signs of diabetic retinopathy. In less than a minute 
the computer stratifies eyes into two groups. Group 1 contains eyes that are nega-
tive or demonstrate mild diabetic retinopathy while Group 2 contains eyes with 
stages more advanced than mild diabetic retinopathy. Group 1 can be retested in 
12 months while group 2 is referred to an eye care specialist. A recent study dem-
onstrated IDx-DR to have similar sensitivity in detecting diabetic retinopathy to 
human experts [47].
With future system improvement, the integration of this intelligent screen-
ing system in a portable fundus camera or a smartphone will greatly improve its 
accessibility to remote regions. Moreover, having the ability to diagnose diabetic 
retinopathy (and other ocular diseases in the future) in a matter of few seconds will 
provide the efficiency to screen larger populations. This new emerging AI technol-
ogy is a major breakthrough in global health and will serve to positively impact the 
visual health of millions of patients.
Another major cause of visual impairment worldwide is uncorrected refractive 
error. In fact, it is considered to be the leading cause of visual impairment world-
wide, as more than 650 million people suffer from lack of adequate refractive error 
Figure 13. 
IDx-DR uses artificial intelligence to detect diabetic retinopathy without the need for experienced 
ophthalmologic personnel.
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correction [48, 49]. It is estimated that the resulting visual impairment contributes 
to more than 250 billion dollars in productivity loss [48]. This loss of income can be 
very detrimental, especially to low-income countries where individuals make less 
than one dollar a day. Providing adequate vision screening and refractive error cor-
rection can be very cost effective. A study called PROductivity Study of Presbyopia 
Elimination in Rural-dwellers (PROSPER), was published in 2018 showed a clear 
link between refractive error correction and productivity increase [50]. The study 
conducted in India looked at tea pickers with uncorrected refractive error. It found 
that providing workers with corrective lenses improved their productivity by 21.7%. 
Therefore, providing adequate screening and eyeglasses offers an easy solution for 
the reversal of low vision and blindness, leading to improved quality of life and 
economic development worldwide. In fact, the WHO considers refractive error as 
one of the priority eye diseases that it aims to combat globally.
Phoropter is the most widely used tools by ophthalmologists and optometrists to 
measure patients’ refractive error and determine the eyeglass prescription strength. 
It relies on a heavy set of numerous spherical and cylindrical lenses of various pow-
ers. A large number of lenses is required for examination since, eyecare providers 
must cover the refractive error conditions such as myopia, hyperopia, and astigma-
tism, along with their respective degree of impairment. This can make mobility of 
eye care personnel and transportation of equipment between sites a burdensome 
task, especially in remote areas where road systems are underdeveloped. Moreover, 
the process of finding the proper prescription strength requires constant patient 
feedback in order to determine the lens power that provides the sharpest image. It 
is a very time-consuming process that can limit the number of patients seen by an 
eye specialist. Moreover, the communication element can be very challenging in 
certain populations such as children and elderly or patients with mental disabilities 
or cognitive impairments. It also requires either the eyecare providers speak the 
language of their patients or the availability of an interpreter in order for the test to 
be completed. This can force providers to avoid regions where language is a barrier.
A solution to the aforementioned limitations is currently being developed by a 
team from Tucson, Arizona called the auto-phoropter [51]. The auto-phoropter is 
a low-cost handheld device that is able to measure a patient’s refractive without the 
need of patient’s feedback. In contrast to the already available autorefractors, the 
auto-phoropter does not require fine tuning of patient’s refractive error measure-
ment with an additional exam using lens trials. The special system of lenses and 
sensors in the auto-phoropter make measuring the refractive error possible. The 
device contains three separate fluidic lenses, two cylindrical lenses that are placed 
45° with respect to each other for astigmatism correction and a spherical lens for 
myopia/hyperopia. Through pressure induced deformation by the liquid that is 
pumped in and out of the lens, the power of the fluidic lens can be tuned in incre-
ments of 0.1 diopters. With a special wavefront sensor which measures the infrared 
wavefront coming from the eye called Shack-Hartmann, the refractive error can be 
calculated in matter of seconds. As a result, the device portability, lack of patient’s 
subjective feedback and the prompt corrective error measurement, the auto-
phoropter will allow large patient population screening without the need of trained 
eye specialists.
According to one estimate, there are more than 1 billion people above the age of 35 
that are suffering from uncorrected presbyopia while more than 200 million people 
suffer from moderate and severe vision impairment (<6/18 but better than 3/60) 
[52]. Giving patients eyeglasses after vision testing will ensure that they receive the 
appropriate intervention instead of solely providing them with a prescription. There 
are various of factors that might impair patients from following up and getting their 
custom-made glasses. These factors include cost and lack of perceived benefit to name 
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a few. Therefore, as expected, it will be much more likely that patients wear eyeglasses 
if offered for free, rather than for purchase [50]. For this reason, we recommend that 
screening programs carry both reading and prescription glasses to cover the whole 
spectrum of refraction errors, especially in areas that lack the appropriate facilities 
and resources.
Nevertheless, being able to carry large number of glasses can be challenging 
both logistically and financially. Ordering eyeglasses in bulk will help lower their 
individual cost. We found that in some factories in China, manufacturing a pair of 
reading glasses can cost as little as USD 0.50 while a prescription glasses for myopia 
can cost around USD 1.50. Adjustable glasses can be a solution to reducing the 
number of eyeglass carried by screening programs. However, this advanced type of 
eyeglasses is more expensive, as a pair can cost around USD 19.
6. Conclusion
This chapter outlined various emerging diagnostic tools and resources that 
aim to assist in the fight against preventable blindness and achieve the mission of 
Vision 2020. From Web-based databases and global organizations to smartphone 
applications and diagnostic devices, eye care providers have emerging diagnostic 
tools to promote visual health and increase access in global underserved areas. We 
hope that with the continual evolution of technology, and with improved accessibil-
ity and affordability of visual care, preventable blindness can be 1 day eliminated 
worldwide.
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